Shares of Synairgen plc (LON:SNG – Get Free Report) crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 5.29 ($0.07) and traded as high as GBX 7.59 ($0.09). Synairgen shares last traded at GBX 6.50 ($0.08), with a volume of 98,403 shares traded.
Synairgen Trading Down 9.6 %
The company has a current ratio of 6.77, a quick ratio of 6.35 and a debt-to-equity ratio of 0.09. The firm has a market capitalization of £12.12 million, a P/E ratio of -130.00 and a beta of -2.23. The firm has a 50-day moving average of GBX 5.29 and a two-hundred day moving average of GBX 6.22.
Synairgen Company Profile
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.
See Also
- Five stocks we like better than Synairgen
- What Does Downgrade Mean in Investing?
- The Charles Schwab Company Can Hit New Highs
- Profitably Trade Stocks at 52-Week Highs
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- 5 discounted opportunities for dividend growth investors
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.